Neurodegenerative diseases of infancy and childhood. (Part I)
Jain, S.; Maheshwari, M.C.
Indian Pediatrics 22(10): 767-775
1985
ISSN/ISBN: 0019-6061 PMID: 3915298 Document Number: 257214
Document emailed within 1 workday
Related Documents
Behera, S.K.; Mohapatra, S.S.; Kar, S.; Das, D.; Panda, C. 1979: Bacteriological study of diarrhoea in infancy and childhood (part I) Indian Pediatrics 16(5): 421-427Laverda, A.M.; Degan, E.; Casara, G.L.; Monciotti, C.; Fassetta, G.; Drigo, P.; Carollo, C.; Marin, G. 1981: Value and limits of C.T. scan in neurologics diseases in infancy and childhood La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 3(6): 545-549
Gornig, H. 1976: Etiology and pathogenesis of optic nerve diseases in infancy and early childhood Kinderarztliche Praxis 44(9): 418-423
Shapiro, F.; Bresnan, M.J. 1982: Orthopaedic management of childhood neuromuscular disease. Part III: diseases of muscle Journal of Bone and Joint Surgery. American Volume 64(7): 1102-1107
Barranco-Quintana, J.L.; Allam, M.F.; Del Castillo, A.S.; Navajas, R.F.-C. 2007: Neurodegenerative diseases and tea Revista de Neurologia 44(6): 381-382
Morselli, L.L.; Bogazzi, F.; Cecconi, E.; Genovesi, M.; Martino, E.; Gasperi, M. 2008: Hypopituitarism (GHD) and neurodegenerative diseases Journal of Endocrinological Investigation 31(9 Suppl): 39-43
Bain, L. 1996: Neurodegenerative diseases: sustaining hope Professional Nurse 11(8): 515-516
De la Monte, S.M.; Sohn, Y.K.; Ganju, N.; Wands, J.R. 1998: P53- and CD95-associated apoptosis in neurodegenerative diseases Laboratory Investigation; a Journal of Technical Methods and Pathology 78(4): 401-411
Segura, T.; Galindo, M.F.; Rallo-Gutiérrez, B.; Ceña, V.; Jordán, J. 2003: Pharmacological targets in neurodegenerative diseases Revista de Neurologia 36(11): 1047-1057
Zhao, B.; Zhong, M.; Jin, K. 2008: Neurogenesis and neurodegenerative diseases in human Panminerva Medica 50(1): 55-64
Martin-Rendon, E.; Azzouz, M.; Mazarakis, N.D. 2001: Lentiviral vectors for the treatment of neurodegenerative diseases Current Opinion in Molecular Therapeutics 3(5): 476-481
Ingelsson, M.; Nilsson, L.; Basun, H.; Aquilonius, S.-M.; Lannfelt, L. 2005: Conformationally altered proteins cause neurodegenerative diseases Lakartidningen 102(47): 3542
Iribarren, P.; Cui, Y.-H.; Le, Y.; Wang, J.M. 2002: The role of dendritic cells in neurodegenerative diseases Archivum Immunologiae et Therapiae Experimentalis 50(3): 187-196
Lorenz, R. 2002: A casuistic rationale for the treatment of spastic and myocloni in a childhood neurodegenerative disease: neuronal ceroid lipofuscinosis of the type Jansky-Bielschowsky Neuro Endocrinology Letters 23(5-6): 387-390
Hatakeyama, S. 2006: Neurodegenerative diseases regulated by ubiquitin-proteasome system Rinsho Shinkeigaku 46(11): 890-892
Levy, R. 2000: Neuropsychological evaluation: a useful clinical tool for neurodegenerative diseases Revue Neurologique (Paris) 156(4): 415-426
Cavallucci, V.; Nobili, A.; D'Amelio, M. 2013: Emerging role of mitochondria dysfunction in the onset of neurodegenerative diseases Journal of Biological Regulators and Homeostatic Agents 27(2 Suppl): 1-9
Madrazo, I.; Castrejón, H.; Franco-Bourland, R.E. 1994: Human brain drafting: an approach to the treatment of neurodegenerative diseases Surgical Technology International 3: 493-499
Nivet-Antoine, V.; Coulhon, M-P.; Le Denmat, C.; Hamon, B.; Dulcire, X.; Lefebvre, M.; Piette, F.; Davous, P.; Durand, D.; Duchassaing, D. 2003: Apolipoprotein E and bleomycin hydrolase. Polymorphisms: association with neurodegenerative diseases Annales de Biologie Clinique 61(1): 61-67
Wurtman, R.J.; Blusztajn, J.K.; Ulus, I.H.; Coviella, I.L.; Buyukuysal, R.L.; Growdon, J.H.; Slack, B.E. 1990: Choline metabolism in cholinergic neurons: implications for the pathogenesis of neurodegenerative diseases Advances in Neurology 51: 117-125